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BALLOON-EXPANDABLE METALLIC STENTS IN THE MANAGEMENT OF 
TRACHEOMALACIA IN NEONATES 
Giuseppe Santoro, MD, a Sergio Picardo, MD, b Giuseppina Testa, MD, b Roberto Formigari, MD, a 
Stefano Marianeschi, MD, c Glauco Catena, MD, b and Luigi Ballerini, MD," Rome, Italy 
Tracheomalacia s a challenging problem after opera- 
tions for certain congenital heart malformations in neo- 
nates and infants. 1It may often prevent he patients from 
being weaned from mechanical ventilation. Management 
of this condition remains difficult. Many surgical ap- 
proaches have been suggested, although none of them is 
universally accepted. 2 Conversely, a major role could be 
played by stent implantation at the level of the malacic 
segment. However, both silicone stents and self-expanding 
metallic stents present major technical or physiologic 
problems in pediatric patients. 35 This article reports on 
our preliminary experience with the use of endovascular 
balloon-expandable metallic stents in the treatment of 
neonatal tracheomalacia after surgical repair of congeni- 
tal heart malformations. 
Patient population. During 1993, three patients (Table 
I) were subjected to implantation of a balloon-expandable 
metallic stent at the airway level. The stent was used to 
treat racheobronchial malacia that caused failure to wean 
from assisted ventilation after operations for congenital 
cardiovascular malformations. In each case, informed 
parental consent was obtained before stent implantation. 
Technique. The morphologic features of the malacic 
segment were evaluated by tracheography during sponta- 
neous respiration. Peak respiratory pressure and pulmo- 
nary compliance were measured before and after stent 
implantation by a Capnomac Ultima monitor (Datex 
Medical Instrumentation, Tewksbury, Mass.). Endovascu- 
lar balloon-expandable Palmaz-Schatz stents (Johnson & 
Johnson, New Brunswick, N.J.), 128 mm long, were used 
to support the tracheomalacic segment. The stent was 
mounted on the Lo-Bow (Mallinckrodt Medical, Inc., St. 
Louis, Mo.) 6 mm balloon guidewire (0.035 inch) and 
positioned, under fluoroscopic guidance, at the level of 
the malacic segment through the endotracheal tube used 
for mechanical ventilation. After the endotracheal tube 
had been withdrawn as far as possible, mechanical venti- 
lation was briefly suspended and the balloon rapidly 
inflated to expand the stent. 
Statistical analysis. Morphologic and functional data 
were expressed as mean values _-2-1 standard deviation. 
Statistical analysis was performed by the paired Student's 
t test. 
Results. Balloon-expandable stent implantation was 
simply, quickly, and successfully performed in all cases. 
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On the whole, assisted ventilation was stopped for about 
30 to 45 seconds, and the mean time for the entire 
procedure was about 5 minutes. No significant adverse 
side-effects were recorded. Two patients were extubated 
soon after the procedure and the third after 1 week of 
assisted ventilation. After stent implantation, the diame- 
ter of the tracheomalacic segment increased from 4.8 --- 
0.2 to 6.0 +- 0.3 mm (+32.4%,p < 0.05) (Figs. 1 and 2); 
peak respiratory pressure decreased from 41 -+ 3.6 to 13.7 
_+ 9.3 cm H20 (-66.6%, p < 0.01); and pulmonary 
compliance increased from 7 --- 1 to 12.3 -+ 2.5 ml/cm H20 
(+44.1%,p < 0.05). The first two patients died, 2 and 3 
weeks, respectively, after stent implantation, because of 
intractable sepsis from gram-negative bacteria. 
Discussion. Tracheobronehial malacia is an infre- 
quent but potentially life-threatening clinical problem 
in the postoperative course of neonates and infants 
undergoing operations for congenital cardiovascular 
malformations. Vascular rings or slings are the most 
frequently diagnosed lesions causing compression and 
hence malacic degeneration of the tracheobronchial 
tree~; this degeneration results in inspiratory collapse 
of the airway tree and leads to postoperative inability to 
wean the patient from mechanical ventilation. To date, 
many therapeutic approaches have been suggested, 24 
none of which has been accepted with confidence in 
pediatric patients. In fact, the surgical approach of 
patching, resecting, or suspending the tracheomalacic 
segment has not been widely embraced. 5 Conversely, 
implantation of endoluminal stents that give rigid sup- 
port to the malacic segment and thereby prevent in- 
spiratory collapse seems to be a useful option. 2-4 
Silicone stents and self-expanding metallic stents have 
been proposed for use in children. 3' 4 Silicone stents have 
the major advantages of being easy to implant, amenable 
to fine adjustment after insertion, well tolerated, and 
possibly retrievable. However, bronchoscopic guidance is 
frequently necessary for implantation, and the stents tend 
to migrate distally over time. Furthermore, because the 
prosthesis does not become epithelialized, the area cov- 
ered by the silicone stent is devoid of the normal muco- 
ciliary clearance mechanism and becomes prone to mucus 
accumulation and secondary infections. 3 
Self-expanding metallic stents eem more useful for the 
treatment of tracheomalacia in children: they are easily 
implanted, well tolerated, and do not affect the mucocili- 
ary function of the site of implantation, because they are 
eventually covered by ciliated columnar epithelium. How- 
ever, bronchoscopic guidance is needed to implant hem, 
and their diameter may not be suited to the size of the 
patient's trachea, so that they cannot be easily used in 
neonates and infants. Conversely, endovascular balloon- 
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Fig. 1. A, Preoperative bronchography, showing the malacic segment (arrows). B, Bronchial diameter 
increase after balloon-expandable st nt implantation. 
Table I. Clinical data of the patients ubmitted to endoluminal stent implantation 
Period of 
Site of stent mechanical Time to 
Age Cardiac anomaly implantation ventilation extubation 
1 2 mo Scimitar syndrome Left bronchus 8 wk 1 wk 
2 2 mo Left PA sling Trachea 6 wk 2 hr 
3 2 mo Double aortic arch Trachea 6 wk 15 min 
PA, Pulmonary artery. 
expandable stents 6 are easily implanted with merely 
fluoroscopic guidance, and they do not interfere with 
the epithelial mucociliary function; thus the risk of 
mucus accumulation and possible subsequent infections 
is lessened. Again, it might be possible to suit their 
diameter to the size of the child's trachea by using 
adequate-sized expanding balloons and by redilating 
the stent over the time, to progressively suit its diame- 
ter to the tracheal size during the patient's growth. 
However, like other metallic stents, the balloon-ex- 
pandable stent, once placed, cannot be adjusted or 
moved easily, if at all. 
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Fig. 2. A, Preoperative tracheography showing the malacic segment (arrows). B, Tracheal diameter increase 
after balloon-expandable stent implantation. 
In our study, the clinical condition and respiratory func- 
tional parameters of the patients ignificantly improved early 
after stent implantation. All patients whose tubes had pre- 
viously been considered unremovable because failure of 
several methods, including synchronized intermittent man- 
datory ventilation, with or without either pressure support or 
continuous positive airway pressure, were easily weaned 
from mechanical ventilation early after the procedure. Un- 
fortunately, after this dramatic improvement, wo of the 
patients died of intractable sepsis 2 and 3 weeks later. 
However, at the time of stent implantation, they were 
already critically ill, having clinical and laboratory evidence 
of sepsis and several blood cultures positive for gram- 
negative organisms (Klebsiella spp.). Furthermore, in the 
second patient, a large endocardial septic vegetation at the 
cavoatrial junction had been visualized by echocardiography 
long before stent implantation. 
In conclusion, we think that the infective problems 
recorded in our series cannot be related in any way to 
stent implantation. In fact, more aggressive management 
of tracheomalacia by earlier stent implantation might 
have avoided prolonged assisted ventilation and lessened 
the likelihood of secondary infections. This approach may 
have lowered the morbidity and mortality in our series. 
Conclusions. Our preliminary results with implantation 
of an endovascular balloon-expandable metallic stent at 
the airway level of critically ill infants are promising. Our 
experience is limited, and a longer follow-up period is 
needed to confirm our preliminary data. However, we 
suggest hat this safe and effective procedure should be 
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strongly considered as an alternative treatment for chil- 
dren with tracheomalacia. 
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TRUNCUS REPAIR WITH A VALVELESS CONDUIT IN NEONATES 
Douglas M. Behrendt, MD, and Macdonald Dick IlI, MD, Iowa City, Iowa, and Ann Arbor, Mich. 
In 1984, we reported the successful se of 8 and 10 mm 
polytetrafluoroethylene (PTFE) tubes to connect he right 
ventricle to the pulmonary arteries in the repair of truncus 
arteriosus types I and II in the neonate (Fig. 1). 1 These 
infants were operated on at the ages of 1 to 9 days because 
of severe heart failure. At that time, the smallest commer- 
cially available conduit was a 12 mm Dacron polyester 
tube containing a porcine heterograft valve. Although this 
device was used successfully by Ebert and coworkers 2 in a 
large series of infant truncus repairs, it was too cumber- 
some for insertion into the neonates in our series, who 
ranged in weight from 2.1 to 3.3 kg. Allografts were not in 
general use at that time. 
These PTFE tubes were technically relatively easy to 
insert, yet we were concerned that neonates would not be 
able to tolerate the pulmonary insufficiency created by 
unvalved conduits. Although the first successful repairs of 
right ventricle-pulmonary artery discontinuity had used 
nonvalved tubes, these operations were performed on 
older children, who had anatomy that restricted pulmo- 
nary blood flow and therefore had a low pulmonary 
resistance. 3 Our fears proved unfounded. Five of the 
seven infants survived the operation, and the two who 
died did so of unrelated conditions. 
Our second major concern was that these small tubes 
would require replacement at an early age, committing 
these infants to multiple revisionary operations. This 
also has not proved to be the case. As outlined in Table 
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Fig. 1. Repair of truncus arteriosus with a PTFE conduit. 
I, PTFE tubes in the four long-term survivors lasted for 
3 to 11 years, when it was possible to insert allografts of 
19 to 25 mm diameter. Each patient was found to have 
stenosis at the origin of one or both pulmonary artery 
